Last reviewed · How we verify
ACD856
At a glance
| Generic name | ACD856 |
|---|---|
| Sponsor | AlzeCure Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 (EARLY_PHASE1)
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856 (PHASE1)
- Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACD856 CI brief — competitive landscape report
- ACD856 updates RSS · CI watch RSS
- AlzeCure Pharma portfolio CI